Detalles de la búsqueda
1.
Redo-aortic valve replacement in prior stentless prosthetic aortic valves: Transcatheter versus surgical approach.
Catheter Cardiovasc Interv
; 99(1): 181-192, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34402588
2.
A novel technique for postclosure of large-bore sheaths using two Perclose devices.
Catheter Cardiovasc Interv
; 97(5): 905-909, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098361
3.
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
Circ Res
; 122(3): 479-488, 2018 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29208679
4.
A comparison of valve-in-valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves.
Catheter Cardiovasc Interv
; 93(6): 1106-1115, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30588736
5.
Comparison of paravalvular aortic leak characteristics in the Medtronic CoreValve versus Edwards Sapien Valve: Paravalvular aortic leak characteristics.
Catheter Cardiovasc Interv
; 92(5): 972-980, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29726601
6.
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
Circ Res
; 116(1): 99-107, 2015 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25406300
7.
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
Am Heart J
; 179: 142-50, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27595689
8.
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
Circ Res
; 115(10): 867-74, 2014 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25136078
9.
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
JAMA
; 307(16): 1717-26, 2012 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-22447880
10.
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
JAMA
; 308(22): 2380-9, 2012 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23129008
11.
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
JAMA
; 306(19): 2110-9, 2011 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-22084195
12.
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.
Am Heart J
; 160(2): 215-23, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20691824
13.
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
Am Heart J
; 158(3): 356-63, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19699857
14.
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.
Cell Transplant
; 25(9): 1675-1687, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26590374
15.
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).
J Cardiovasc Transl Res
; 3(1): 30-6, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20445812
16.
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
Tex Heart Inst J
; 37(4): 412-20, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20844613
17.
Treatment of unprotected left main coronary artery stenosis in a 5-year-old heart transplant patient using a sirolimus-eluting stent.
J Heart Lung Transplant
; 26(10): 1061-4, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17919628
Resultados
1 -
17
de 17
1
Próxima >
>>